Scripps VIVO scripps research logo

  • Index
  • Log in
  • Home
  • People
  • Organizations
  • Research
  • Events
Search form
As of April 1st VIVO Scientific Profiles will no longer updated for faculty, and the link to VIVO will be removed from the library website. Faculty profile pages will continue to be updated via Interfolio. VIVO will continue being used behind the scenes to update graduate student profiles. Please contact helplib@scripps.edu if you have questions.
How to download citations from VIVO | Alternative profile options

De novo identification of VRC01 class HIV-1-neutralizing antibodies by next-generation sequencing of B-cell transcripts

Academic Article
uri icon
  • Overview
  • Research
  • Identity
  • Additional Document Info
  • View All
scroll to property group menus

Overview

authors

  • Zhu, Jiang
  • Wu, X.
  • Zhang, B.
  • McKee, K.
  • O'Dell, S.
  • Soto, C.
  • Zhou, T.
  • Casazza, J. P.
  • NISC Comparative Sequencing Program
  • Mullikin, J. C.
  • Kwong, P. D.
  • Mascola, J. R.
  • Shapiro, L.

publication date

  • October 2013

journal

  • Proceedings of the National Academy of Sciences of the United States of America  Journal

abstract

  • Next-generation sequencing of antibody transcripts provides a wealth of data, but the ability to identify function-specific antibodies solely on the basis of sequence has remained elusive. We previously characterized the VRC01 class of antibodies, which target the CD4-binding site on gp120, appear in multiple donors, and broadly neutralize HIV-1. Antibodies of this class have developmental commonalities, but typically share only ∼50% amino acid sequence identity among different donors. Here we apply next-generation sequencing to identify VRC01 class antibodies in a new donor, C38, directly from B cell transcript sequences. We first tested a lineage rank approach, but this was unsuccessful, likely because VRC01 class antibody sequences were not highly prevalent in this donor. We next identified VRC01 class heavy chains through a phylogenetic analysis that included thousands of sequences from C38 and a few known VRC01 class sequences from other donors. This "cross-donor analysis" yielded heavy chains with little sequence homology to previously identified VRC01 class heavy chains. Nonetheless, when reconstituted with the light chain from VRC01, half of the heavy chain chimeric antibodies showed substantial neutralization potency and breadth. We then identified VRC01 class light chains through a five-amino-acid sequence motif necessary for VRC01 light chain recognition. From over a million light chain sequences, we identified 13 candidate VRC01 class members. Pairing of these light chains with the phylogenetically identified C38 heavy chains yielded functional antibodies that effectively neutralized HIV-1. Bioinformatics analysis can thus directly identify functional HIV-1-neutralizing antibodies of the VRC01 class from a sequenced antibody repertoire.

subject areas

  • Amino Acid Sequence
  • Antibodies, Neutralizing
  • B-Lymphocytes
  • Base Sequence
  • Genetic Variation
  • HIV-1
  • High-Throughput Nucleotide Sequencing
  • Humans
  • Immunoglobulin Heavy Chains
  • Immunoglobulin Light Chains
  • Molecular Sequence Data
  • Phylogeny
  • Sequence Homology, Amino Acid
scroll to property group menus

Research

keywords

  • DNA sequencing
  • antibodyomics
  • cross-donor phylogenetic analysis
  • humoral immune response
  • sequence signature
scroll to property group menus

Identity

PubMed Central ID

  • PMC3808619

International Standard Serial Number (ISSN)

  • 0027-8424

Digital Object Identifier (DOI)

  • 10.1073/pnas.1306262110

PubMed ID

  • 24106303
scroll to property group menus

Additional Document Info

start page

  • E4088

end page

  • E4097

volume

  • 110

issue

  • 43

©2022 The Scripps Research Institute | Terms of Use | Powered by VIVO

  • About
  • Contact Us
  • Support